| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.759 | 0.005 | 0.759 | Aldehyde oxidase inhibitor | |||
| 0.75 | 0.018 | 0.822 | Caspase 9 stimulant | 0.822 0.008 CID_66709879 | CID_66709879 | |
| 0.732 | 0.003 | 0.732 | Alcohol oxidase inhibitor | 0.101 0.018 CID_66709879 | ||
| 0.693 | 0.007 | 0.693 | 5 Hydroxytryptamine release stimulant | 0.56 0.019 CID_66709879 | ||
| 0.686 | 0.002 | 0.686 | Succinate dehydrogenase inhibitor | 0.263 0.018 CID_66709879 | ||
| 0.686 | 0.003 | 0.785 | Alpha-N-acetylglucosaminidase inhibitor | 0.785 0.002 CID_66709879 | CID_66709879 | |
| 0.676 | 0.005 | 0.685 | 5 Hydroxytryptamine release inhibitor | 0.685 0.005 CID_66709879 | CID_66709879 | |
| 0.662 | 0.011 | 0.887 | Cholesterol antagonist | 0.887 0.003 CID_66709879 | CID_66709879 | |
| 0.613 | 0.006 | 0.613 | Superoxide dismutase inhibitor | |||
| 0.597 | 0.012 | 0.726 | Immunomodulator | 0.726 0.005 CID_66709879 | CID_66709879 | |
| 0.589 | 0.004 | 0.589 | Aldehyde dehydrogenase inhibitor | 0.384 0.006 CID_66709879 | ||
| 0.579 | 0.012 | 0.806 | Histamine release inhibitor | 0.806 0.003 CID_66709879 | CID_66709879 | |
| 0.584 | 0.018 | 0.715 | Vasodilator, peripheral | 0.715 0.005 CID_66709879 | CID_66709879 | |
| 0.561 | 0.013 | 0.561 | GABA C receptor rho-3 antagonist | |||
| 0.554 | 0.005 | 0.678 | Anesthetic general | 0.678 0.004 CID_66709879 | CID_66709879 | |
| 0.553 | 0.02 | 0.632 | Immunosuppressant | 0.632 0.009 CID_66709879 | CID_66709879 | |
| 0.528 | 0.008 | 0.528 | Peroxidase inhibitor | |||
| 0.522 | 0.005 | 0.522 | Phospholipase C inhibitor | 0.467 0.007 CID_66709879 | ||
| 0.494 | 0.012 | 0.874 | Angiogenesis stimulant | 0.874 0.003 CID_66709879 | CID_66709879 | |
| 0.487 | 0.014 | 0.516 | Hypolipemic | 0.516 0.011 CID_66709879 | CID_66709879 | |
| 0.482 | 0.01 | 0.602 | Interleukin 2 agonist | 0.602 0.003 CID_66709879 | CID_66709879 | |
| 0.476 | 0.019 | 0.78 | Vasodilator, coronary | 0.78 0.004 CID_66709879 | CID_66709879 | |
| 0.468 | 0.014 | 0.468 | Psychostimulant | 0.339 0.034 CID_66709879 | ||
| 0.477 | 0.032 | 0.848 | Antithrombotic | 0.848 0.003 CID_66709879 | CID_66709879 | |
| 0.444 | 0.008 | 0.444 | 5 Hydroxytryptamine uptake stimulant | 0.194 0.165 CID_66709879 | ||
| 0.438 | 0.014 | 0.647 | Interleukin agonist | 0.647 0.004 CID_66709879 | CID_66709879 | |
| 0.42 | 0.007 | 0.466 | Protein kinase stimulant | 0.466 0.005 CID_66709879 | CID_66709879 | |
| 0.408 | 0.01 | 0.408 | Bone formation stimulant | 0.171 0.045 CID_66709879 | ||
| 0.441 | 0.046 | 0.441 | Toll-Like receptor agonist | 0.22 0.179 CID_66709879 | ||
| 0.418 | 0.024 | 0.552 | Platelet antagonist | 0.552 0.009 CID_66709879 | CID_66709879 | |
| 0.408 | 0.02 | 0.523 | DNA synthesis inhibitor | 0.523 0.012 CID_66709879 | CID_66709879 | |
| 0.429 | 0.042 | 0.678 | Immunostimulant | 0.678 0.009 CID_66709879 | CID_66709879 | |
| 0.394 | 0.009 | 0.394 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.388 | 0.005 | 0.388 | Neurotrophic factor | 0.189 0.033 CID_66709879 | ||
| 0.4 | 0.023 | 0.573 | Vasodilator | 0.573 0.007 CID_66709879 | CID_66709879 | |
| 0.411 | 0.038 | 0.555 | Spasmolytic | 0.555 0.017 CID_66709879 | CID_66709879 | |
| 0.377 | 0.006 | 0.377 | Gastrin inhibitor | 0.307 0.028 CID_66709879 | ||
| 0.373 | 0.005 | 0.373 | Interleukin 4 antagonist | 0.353 0.006 CID_66709879 | ||
| 0.37 | 0.004 | 0.37 | Ornithine carbamoyltransferase inhibitor | 0.134 0.011 CID_66709879 | ||
| 0.465 | 0.103 | 0.844 | Antiinflammatory | 0.844 0.01 CID_66709879 | CID_66709879 | |
| 0.432 | 0.075 | 0.834 | Cyclophilin D inhibitor | 0.834 0.005 CID_66709879 | CID_66709879 | |
| 0.358 | 0.004 | 0.358 | Adenylate kinase inhibitor | 0.337 0.005 CID_66709879 | ||
| 0.357 | 0.004 | 0.357 | Catalase inhibitor | 0.106 0.037 CID_66709879 | ||
| 0.357 | 0.004 | 0.357 | Ferrochelatase inhibitor | |||
| 0.381 | 0.033 | 0.381 | Calcium channel activator | 0.241 0.158 CID_66709879 | ||
| 0.345 | 0.004 | 0.345 | Alcohol dehydrogenase inhibitor | 0.225 0.01 CID_66709879 | ||
| 0.372 | 0.033 | 0.717 | Hypoglycemic | 0.717 0.005 CID_66709879 | CID_66709879 | |
| 0.368 | 0.029 | 0.368 | Sodium/bile acid cotransporter inhibitor | 0.281 0.096 CID_66709879 | ||
| 0.345 | 0.007 | 0.345 | GABA C receptor agonist | |||
| 0.356 | 0.023 | 0.356 | RNA-directed DNA polymerase inhibitor | 0.288 0.034 CID_66709879 | ||
| 0.355 | 0.024 | 0.49 | Cyclic AMP phosphodiesterase inhibitor | 0.49 0.007 CID_66709879 | CID_66709879 | |
| 0.334 | 0.004 | 0.472 | Triose-phosphate isomerase inhibitor | 0.472 0.003 CID_66709879 | CID_66709879 | |
| 0.334 | 0.011 | 0.334 | Neurotrophic factor enhancer | 0.281 0.024 CID_66709879 | ||
| 0.331 | 0.01 | 0.343 | Phospholipase A2 inhibitor | 0.343 0.009 CID_66709879 | CID_66709879 | |
| 0.321 | 0.004 | 0.461 | Photosensitizer | 0.461 0.003 CID_66709879 | CID_66709879 | |
| 0.32 | 0.004 | 0.32 | Creatine kinase inhibitor | 0.101 0.059 CID_66709879 | ||
| 0.317 | 0.005 | 0.317 | Electron transport complex I inhibitor | 0.101 0.08 CID_66709879 | ||
| 0.314 | 0.002 | 0.314 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.377 | 0.069 | 0.377 | Toll-Like receptor 7 agonist | |||
| 0.312 | 0.004 | 0.312 | GABA C receptor antagonist | |||
| 0.31 | 0.005 | 0.458 | Phosphofructokinase-1 inhibitor | 0.458 0.003 CID_66709879 | CID_66709879 | |
| 0.403 | 0.098 | 0.403 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.307 | 0.003 | 0.38 | Interferon agonist | 0.38 0.002 CID_66709879 | CID_66709879 | |
| 0.312 | 0.01 | 0.464 | UDP-glucose 4-epimerase inhibitor | 0.464 0.004 CID_66709879 | CID_66709879 | |
| 0.331 | 0.029 | 0.331 | Platelet aggregation inhibitor | 0.212 0.073 CID_66709879 | ||
| 0.313 | 0.011 | 0.313 | Anesthetic local | |||
| 0.382 | 0.085 | 0.682 | Antibacterial | 0.682 0.01 CID_66709879 | CID_66709879 | |
| 0.301 | 0.005 | 0.301 | Farnesoid X receptor antagonist | 0.147 0.056 CID_66709879 | ||
| 0.367 | 0.072 | 0.714 | Transcription factor NF kappa B inhibitor | 0.714 0.019 CID_66709879 | CID_66709879 | |
| 0.306 | 0.019 | 0.533 | Interferon gamma antagonist | 0.533 0.004 CID_66709879 | CID_66709879 | |
| 0.307 | 0.027 | 0.542 | Non-steroidal antiinflammatory agent | 0.542 0.005 CID_66709879 | CID_66709879 | |
| 0.3 | 0.021 | 0.3 | Lipocortins synthesis antagonist | 0.225 0.043 CID_66709879 | ||
| 0.359 | 0.082 | 0.359 | Calpain 2 inhibitor | |||
| 0.296 | 0.019 | 0.395 | Lipid peroxidase inhibitor | 0.395 0.01 CID_66709879 | CID_66709879 | |
| 0.293 | 0.019 | 0.662 | Amylase inhibitor | 0.662 0.003 CID_66709879 | CID_66709879 | |
| 0.299 | 0.025 | 0.423 | Peptidyltransferase inhibitor | 0.423 0.005 CID_66709879 | CID_66709879 | |
| 0.278 | 0.006 | 0.278 | Toll-Like receptor 2 antagonist | 0.184 0.032 CID_66709879 | ||
| 0.285 | 0.013 | 0.36 | DNA polymerase I inhibitor | 0.36 0.008 CID_66709879 | CID_66709879 | |
| 0.318 | 0.051 | 0.478 | DNA damaging | 0.478 0.016 CID_66709879 | CID_66709879 | |
| 0.331 | 0.065 | 0.614 | Apoptosis antagonist | 0.614 0.008 CID_66709879 | CID_66709879 | |
| 0.297 | 0.035 | 0.522 | Platelet adhesion inhibitor | 0.522 0.005 CID_66709879 | CID_66709879 | |
| 0.264 | 0.004 | 0.264 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.281 | 0.021 | 0.281 | Insulin sensitizer | 0.271 0.024 CID_66709879 | ||
| 0.272 | 0.015 | 0.272 | Cholesterol synthesis inhibitor | 0.22 0.023 CID_66709879 | ||
| 0.261 | 0.004 | 0.261 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.38 | 0.123 | 0.718 | Apoptosis agonist | 0.718 0.028 CID_66709879 | CID_66709879 | |
| 0.261 | 0.005 | 0.261 | Vanilloid 1 agonist | 0.241 0.006 CID_66709879 | ||
| 0.285 | 0.029 | 0.285 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.242 0.046 CID_66709879 | ||
| 0.258 | 0.004 | 0.258 | Arachidonic acid antagonist | 0.216 0.02 CID_66709879 | ||
| 0.255 | 0.004 | 0.255 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.254 | 0.005 | 0.254 | Carbamoyl phosphate synthetase inhibitor | 0.122 0.015 CID_66709879 | ||
| 0.258 | 0.009 | 0.289 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.289 0.007 CID_66709879 | CID_66709879 | |
| 0.252 | 0.004 | 0.252 | Sphingomyelinase inhibitor | 0.236 0.005 CID_66709879 | ||
| 0.253 | 0.013 | 0.253 | Aminopeptidase B inhibitor | 0.093 0.07 CID_66709879 | ||
| 0.243 | 0.003 | 0.243 | Acyl-CoA dehydrogenase inhibitor | 0.182 0.006 CID_66709879 | ||
| 0.244 | 0.005 | 0.244 | Vanilloid agonist | 0.101 0.032 CID_66709879 | ||
| 0.306 | 0.068 | 0.306 | Lipoxygenase inhibitor | |||
| 0.299 | 0.062 | 0.695 | Antioxidant | 0.695 0.006 CID_66709879 | CID_66709879 | |
| 0.266 | 0.03 | 0.39 | Thrombolytic | 0.39 0.012 CID_66709879 | CID_66709879 | |
| 0.238 | 0.005 | 0.238 | GABA C receptor rho-1 antagonist | |||
| 0.244 | 0.013 | 0.244 | GABA C receptor rho-2 antagonist | |||
| 0.233 | 0.003 | 0.309 | Interferon inducer | 0.309 0.002 CID_66709879 | CID_66709879 | |
| 0.232 | 0.003 | 0.232 | Sphingosine kinase inhibitor | 0.069 0.026 CID_66709879 | ||
| 0.252 | 0.023 | 0.252 | Interleukin 6 antagonist | 0.213 0.034 CID_66709879 | ||
| 0.232 | 0.005 | 0.232 | Adenylate cyclase stimulant | 0.192 0.017 CID_66709879 | ||
| 0.232 | 0.005 | 0.232 | Interleukin 5 antagonist | 0.112 0.029 CID_66709879 | ||
| 0.232 | 0.007 | 0.232 | MAP3K9 inhibitor | |||
| 0.226 | 0.002 | 0.234 | Ca2+-transporting ATPase inhibitor | 0.234 0.002 CID_66709879 | CID_66709879 | |
| 0.227 | 0.004 | 0.227 | Glycine receptor agonist | 0.211 0.004 CID_66709879 | ||
| 0.245 | 0.023 | 0.245 | Nav1.2 sodium channel blocker | |||
| 0.24 | 0.018 | 0.24 | Toll-Like receptor antagonist | |||
| 0.232 | 0.011 | 0.232 | Carbonic anhydrase III inhibitor | 0.179 0.02 CID_66709879 | ||
| 0.223 | 0.003 | 0.491 | Alpha-mannosidase inhibitor | 0.491 0.001 CID_66709879 | CID_66709879 | |
| 0.235 | 0.018 | 0.304 | ATPase inhibitor | 0.304 0.005 CID_66709879 | CID_66709879 | |
| 0.22 | 0.004 | 0.22 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.255 | 0.042 | 0.255 | Growth hormone agonist | |||
| 0.218 | 0.006 | 0.218 | Prolactin inhibitor | |||
| 0.234 | 0.023 | 0.373 | Insulin secretagoues | 0.373 0.007 CID_66709879 | CID_66709879 | |
| 0.23 | 0.019 | 0.519 | Alkylator | 0.519 0.005 CID_66709879 | CID_66709879 | |
| 0.281 | 0.071 | 0.281 | Insulysin inhibitor | |||
| 0.23 | 0.02 | 0.384 | Cell wall synthesis inhibitor | 0.384 0.007 CID_66709879 | CID_66709879 | |
| 0.216 | 0.007 | 0.216 | Keratolytic | |||
| 0.216 | 0.01 | 0.216 | Porphobilinogen synthase inhibitor | |||
| 0.213 | 0.011 | 0.213 | Mucolytic | 0.191 0.015 CID_66709879 | ||
| 0.209 | 0.006 | 0.209 | Glutamate decarboxylase inhibitor | |||
| 0.204 | 0.003 | 0.204 | Sphingosine kinase 2 inhibitor | |||
| 0.216 | 0.017 | 0.392 | Expectorant | 0.392 0.005 CID_66709879 | CID_66709879 | |
| 0.207 | 0.01 | 0.471 | NADH dehydrogenase inhibitor | 0.471 0.004 CID_66709879 | CID_66709879 | |
| 0.229 | 0.032 | 0.229 | Antipruritic | |||
| 0.213 | 0.016 | 0.213 | Bronchodilator | |||
| 0.211 | 0.015 | 0.493 | Cyclooxygenase 3 inhibitor | 0.493 0.003 CID_66709879 | CID_66709879 | |
| 0.255 | 0.06 | 0.255 | Interleukin antagonist | |||
| 0.203 | 0.008 | 0.203 | Argininosuccinate synthase inhibitor | 0.141 0.012 CID_66709879 | ||
| 0.192 | 0.003 | 0.489 | Mannosidase inhibitor | 0.489 0.001 CID_66709879 | CID_66709879 | |
| 0.222 | 0.033 | 0.222 | Thiol protease inhibitor | |||
| 0.194 | 0.006 | 0.194 | Glutathione S-transferase inhibitor | 0.088 0.05 CID_66709879 | ||
| 0.222 | 0.034 | 0.326 | Melanin inhibitor | 0.326 0.019 CID_66709879 | CID_66709879 | |
| 0.192 | 0.005 | 0.244 | Acetylcholine release stimulant | 0.244 0.004 CID_66709879 | CID_66709879 | |
| 0.196 | 0.009 | 0.196 | Electrolyte absorption antagonist | |||
| 0.189 | 0.003 | 0.189 | Sphingosine kinase 1 inhibitor | 0.045 0.023 CID_66709879 | ||
| 0.232 | 0.047 | 0.232 | Nitric-oxide synthase stimulant | 0.218 0.062 CID_66709879 | ||
| 0.188 | 0.003 | 0.188 | Glucosylceramidase inhibitor | 0.169 0.004 CID_66709879 | ||
| 0.202 | 0.018 | 0.202 | Nav1.1 sodium channel blocker | |||
| 0.221 | 0.037 | 0.298 | Diuretic | 0.298 0.023 CID_66709879 | CID_66709879 | |
| 0.198 | 0.019 | 0.198 | Carbonic anhydrase XV inhibitor | |||
| 0.199 | 0.022 | 0.199 | Antibacterial (Helicobacter pylori) | 0.179 0.028 CID_66709879 | ||
| 0.19 | 0.014 | 0.19 | Gastric antisecretory | |||
| 0.213 | 0.037 | 0.213 | Acetylcholine M1 receptor antagonist | |||
| 0.24 | 0.066 | 0.24 | Neuropeptide Y2 antagonist | |||
| 0.181 | 0.009 | 0.208 | Toll-Like receptor 2 agonist | 0.208 0.007 CID_66709879 | CID_66709879 | |
| 0.173 | 0.002 | 0.227 | Glucose-6-phosphate isomerase inhibitor | 0.227 0.001 CID_66709879 | CID_66709879 | |
| 0.187 | 0.017 | 0.566 | Mediator release inhibitor | 0.566 0.004 CID_66709879 | CID_66709879 | |
| 0.182 | 0.012 | 0.182 | Glutamate dehydrogenase inhibitor | 0.128 0.02 CID_66709879 | ||
| 0.173 | 0.003 | 0.173 | Estrogen-related receptor beta agonist | |||
| 0.178 | 0.009 | 0.178 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.174 | 0.005 | 0.193 | Neuraminidase (influenza) inhibitor | 0.193 0.005 CID_66709879 | CID_66709879 | |
| 0.193 | 0.024 | 0.193 | Cathepsin H inhibitor | |||
| 0.175 | 0.006 | 0.175 | Ornithine decarboxylase inhibitor | 0.132 0.018 CID_66709879 | ||
| 0.183 | 0.016 | 0.183 | Calcium antagonist | |||
| 0.231 | 0.064 | 0.314 | Amyloid beta aggregation inhibitor | 0.314 0.042 CID_66709879 | CID_66709879 | |
| 0.24 | 0.074 | 0.24 | Calpain inhibitor | |||
| 0.187 | 0.022 | 0.187 | Falcipain 3 inhibitor | |||
| 0.273 | 0.109 | 0.273 | Thyroid hormone antagonist | |||
| 0.187 | 0.023 | 0.239 | Microtubule formation inhibitor | 0.239 0.012 CID_66709879 | CID_66709879 | |
| 0.174 | 0.011 | 0.246 | Toll-Like receptor 4 antagonist | 0.246 0.004 CID_66709879 | CID_66709879 | |
| 0.189 | 0.027 | 0.189 | Cystathionine beta-synthase inhibitor | 0.138 0.046 CID_66709879 | ||
| 0.189 | 0.028 | 0.189 | Adenylate cyclase inhibitor | 0.113 0.073 CID_66709879 | ||
| 0.195 | 0.034 | 0.597 | Monophenol monooxygenase inhibitor | 0.597 0.005 CID_66709879 | CID_66709879 | |
| 0.185 | 0.025 | 0.185 | Nav1.6 sodium channel blocker | |||
| 0.196 | 0.037 | 0.196 | Neurotensin receptor agonist | |||
| 0.167 | 0.008 | 0.167 | Cannabinoid CB1 receptor agonist | |||
| 0.204 | 0.046 | 0.204 | Cytidine deaminase inhibitor | |||
| 0.175 | 0.018 | 0.175 | TRPA1 agonist | 0.112 0.069 CID_66709879 | ||
| 0.165 | 0.008 | 0.165 | Lanosterol 14 alpha demethylase inhibitor | 0.088 0.076 CID_66709879 | ||
| 0.186 | 0.029 | 0.186 | Nav1.3 sodium channel blocker | |||
| 0.214 | 0.057 | 0.597 | Hepatoprotectant | 0.597 0.005 CID_66709879 | CID_66709879 | |
| 0.167 | 0.01 | 0.167 | Anabolic | 0.133 0.029 CID_66709879 | ||
| 0.177 | 0.021 | 0.177 | Pregnane X receptor agonist | |||
| 0.175 | 0.021 | 0.175 | Interleukin 8 antagonist | |||
| 0.159 | 0.004 | 0.159 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.206 | 0.053 | 0.206 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.181 | 0.028 | 0.181 | Chelator | |||
| 0.156 | 0.004 | 0.156 | GABA B receptor agonist | |||
| 0.154 | 0.005 | 0.156 | Neuraminidase inhibitor | 0.156 0.005 CID_66709879 | CID_66709879 | |
| 0.152 | 0.003 | 0.152 | Squalene epoxidase inhibitor | 0.107 0.005 CID_66709879 | ||
| 0.159 | 0.011 | 0.159 | Aminopeptidase I inhibitor | |||
| 0.287 | 0.139 | 0.287 | 15-Lipoxygenase inhibitor | |||
| 0.186 | 0.039 | 0.447 | Hemostatic | 0.447 0.005 CID_66709879 | CID_66709879 | |
| 0.181 | 0.035 | 0.184 | CF transmembrane conductance regulator agonist | 0.184 0.033 CID_66709879 | CID_66709879 | |
| 0.149 | 0.004 | 0.149 | Aconitate hydratase inhibitor | |||
| 0.236 | 0.092 | 0.236 | Cardiotonic | |||
| 0.154 | 0.009 | 0.154 | Biliverdin reductase inhibitor | 0.096 0.02 CID_66709879 | ||
| 0.153 | 0.012 | 0.153 | Peroxisome proliferator-activated receptor gamma agonist | 0.093 0.032 CID_66709879 | ||
| 0.149 | 0.009 | 0.149 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.144 0.009 CID_66709879 | ||
| 0.171 | 0.031 | 0.171 | 5-Lipoxygenase inhibitor | |||
| 0.158 | 0.019 | 0.158 | Carbonic anhydrase VI inhibitor | 0.131 0.026 CID_66709879 | ||
| 0.146 | 0.008 | 0.194 | Glycine receptor antagonist | 0.194 0.004 CID_66709879 | CID_66709879 | |
| 0.163 | 0.025 | 0.163 | Protein kinase C gamma inhibitor | 0.102 0.074 CID_66709879 | ||
| 0.223 | 0.085 | 0.491 | Antiamyloidogenic | 0.491 0.017 CID_66709879 | CID_66709879 | |
| 0.254 | 0.116 | 0.254 | Thyroid hormone beta antagonist | |||
| 0.139 | 0.002 | 0.139 | Estrogen-related receptor beta antagonist | |||
| 0.153 | 0.017 | 0.52 | Selectin antagonist | 0.52 0.002 CID_66709879 | CID_66709879 | |
| 0.138 | 0.003 | 0.138 | Lysophosphatidic acid 3 receptor antagonist | 0.067 0.017 CID_66709879 | ||
| 0.154 | 0.019 | 0.154 | DOPA decarboxylase inhibitor | |||
| 0.143 | 0.009 | 0.143 | Bile acid receptor antagonist | 0.106 0.038 CID_66709879 | ||
| 0.155 | 0.021 | 0.155 | Carbonic anhydrase XIII inhibitor | 0.152 0.021 CID_66709879 | ||
| 0.138 | 0.004 | 0.138 | Glutamate (mGluR6) antagonist | 0.081 0.024 CID_66709879 | ||
| 0.14 | 0.006 | 0.14 | Acetyl-CoA transferase inhibitor | 0.055 0.034 CID_66709879 | ||
| 0.14 | 0.008 | 0.14 | CDC25B inhibitor | 0.059 0.053 CID_66709879 | ||
| 0.154 | 0.026 | 0.406 | AMP-activated protein kinase stimulant | 0.406 0.004 CID_66709879 | CID_66709879 | |
| 0.13 | 0.003 | 0.179 | Cytokine production stimulant | 0.179 0.002 CID_66709879 | CID_66709879 | |
| 0.138 | 0.012 | 0.147 | Leukotriene antagonist | 0.147 0.01 CID_66709879 | CID_66709879 | |
| 0.157 | 0.032 | 0.157 | Heat shock protein 70 antagonist | 0.148 0.05 CID_66709879 | ||
| 0.133 | 0.008 | 0.133 | Beta 3 adrenoreceptor antagonist | |||
| 0.151 | 0.027 | 0.151 | Caspase 3 inhibitor | |||
| 0.133 | 0.009 | 0.133 | Cannabinoid CB2 receptor antagonist | |||
| 0.133 | 0.009 | 0.133 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.133 | 0.01 | 0.133 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.137 | 0.015 | 0.137 | CDC25A inhibitor | |||
| 0.139 | 0.018 | 0.139 | Toll-Like receptor 3 antagonist | |||
| 0.126 | 0.005 | 0.126 | Phospholipase D inhibitor | |||
| 0.14 | 0.02 | 0.14 | ABCA1 expression enhancer | |||
| 0.169 | 0.05 | 0.199 | Mannose-6-phosphate isomerase inhibitor | 0.199 0.031 CID_66709879 | CID_66709879 | |
| 0.19 | 0.071 | 0.524 | Nitric oxide antagonist | 0.524 0.014 CID_66709879 | CID_66709879 | |
| 0.122 | 0.005 | 0.122 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.123 | 0.005 | 0.123 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.172 | 0.056 | 0.207 | Hexokinase inhibitor | 0.207 0.031 CID_66709879 | CID_66709879 | |
| 0.121 | 0.005 | 0.121 | Phosphoglycerate kinase inhibitor | 0.042 0.018 CID_66709879 | ||
| 0.135 | 0.02 | 0.135 | Macrophage migration inhibitory factor inhibitor | |||
| 0.12 | 0.005 | 0.12 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.188 | 0.073 | 0.189 | P-glycoprotein inhibitor | 0.189 0.072 CID_66709879 | CID_66709879 | |
| 0.121 | 0.007 | 0.121 | Purinergic P2Y antagonist | 0.107 0.008 CID_66709879 | ||
| 0.206 | 0.093 | 0.623 | Free radical scavenger | 0.623 0.007 CID_66709879 | CID_66709879 | |
| 0.121 | 0.008 | 0.121 | Phosphodiesterase 3B inhibitor | |||
| 0.141 | 0.029 | 0.141 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.119 | 0.007 | 0.17 | Leukotriene B4 antagonist | 0.17 0.004 CID_66709879 | CID_66709879 | |
| 0.187 | 0.076 | 0.322 | DNA methyltransferase I inhibitor | 0.322 0.019 CID_66709879 | CID_66709879 | |
| 0.126 | 0.016 | 0.126 | Lipase inhibitor | 0.086 0.037 CID_66709879 | ||
| 0.139 | 0.029 | 0.139 | Estrogen antagonist | |||
| 0.128 | 0.019 | 0.244 | Phosphodiesterase 6D inhibitor | 0.244 0.004 CID_66709879 | CID_66709879 | |
| 0.112 | 0.004 | 0.112 | Purinergic P2Y12 antagonist | 0.045 0.008 CID_66709879 | ||
| 0.122 | 0.015 | 0.122 | Phosphodiesterase III inhibitor | |||
| 0.116 | 0.008 | 0.116 | Vanilloid 4 agonist | |||
| 0.108 | 0.001 | 0.108 | Lysophosphatidic acid receptor 3 agonist | 0.025 0.004 CID_66709879 | ||
| 0.131 | 0.024 | 0.132 | Thioredoxin inhibitor | 0.132 0.024 CID_66709879 | CID_66709879 | |
| 0.111 | 0.004 | 0.111 | Adenosine deaminase inhibitor | 0.099 0.005 CID_66709879 | ||
| 0.134 | 0.028 | 0.134 | CDC-like kinase 3 inhibitor | |||
| 0.169 | 0.063 | 0.206 | Protein-tyrosine phosphatase inhibitor | 0.206 0.044 CID_66709879 | CID_66709879 | |
| 0.109 | 0.005 | 0.109 | Prostaglandin agonist | 0.03 0.022 CID_66709879 | ||
| 0.109 | 0.005 | 0.109 | Sphingosine 1-phosphate receptor agonist | |||
| 0.106 | 0.002 | 0.106 | Lysophosphatidic acid receptor 1 agonist | 0.03 0.011 CID_66709879 | ||
| 0.115 | 0.012 | 0.115 | Beta adrenoreceptor antagonist | |||
| 0.11 | 0.007 | 0.11 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.121 | 0.019 | 0.121 | Cannabinoid receptor agonist | |||
| 0.19 | 0.088 | 0.19 | MAP kinase kinase 2 inhibitor | |||
| 0.119 | 0.018 | 0.119 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.114 | 0.013 | 0.114 | Carbonic anhydrase VB inhibitor | |||
| 0.124 | 0.024 | 0.124 | Histidine decarboxylase inhibitor | |||
| 0.11 | 0.011 | 0.11 | Potassium channel (ATP-sensitive) blocker | |||
| 0.117 | 0.018 | 0.134 | Na+ K+ transporting ATPase inhibitor | 0.134 0.01 CID_66709879 | CID_66709879 | |
| 0.12 | 0.022 | 0.175 | Glutamate release inhibitor | 0.175 0.006 CID_66709879 | CID_66709879 | |
| 0.117 | 0.019 | 0.117 | mTOR complex 2 inhibitor | |||
| 0.125 | 0.028 | 0.125 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.104 | 0.008 | 0.104 | Potassium channel Kv1.3 blocker | |||
| 0.1 | 0.004 | 0.1 | Membrane dipeptidase inhibitor | |||
| 0.1 | 0.004 | 0.1 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.099 | 0.004 | 0.099 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.038 0.023 CID_66709879 | ||
| 0.133 | 0.038 | 0.133 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.114 | 0.019 | 0.114 | Leukotriene synthesis inhibitor | |||
| 0.107 | 0.012 | 0.107 | Glycine transporter 2 inhibitor | |||
| 0.101 | 0.006 | 0.101 | MDM2 inhibitor | |||
| 0.125 | 0.031 | 0.125 | MAP kinase kinase 1 inhibitor | |||
| 0.104 | 0.01 | 0.104 | MAP kinase kinase 7 inhibitor | |||
| 0.104 | 0.01 | 0.104 | Prostaglandin F2 alpha antagonist | |||
| 0.142 | 0.049 | 0.142 | Acetylcholine muscarinic antagonist | |||
| 0.119 | 0.026 | 0.119 | Adrenaline agonist | |||
| 0.098 | 0.005 | 0.098 | Nicotinic acid receptor agonist | |||
| 0.122 | 0.029 | 0.122 | Histamine N-methyltransferase inhibitor | |||
| 0.097 | 0.004 | 0.097 | Geranyltranstransferase inhibitor | |||
| 0.111 | 0.02 | 0.125 | GABA aminotransferase inhibitor | 0.125 0.014 CID_66709879 | CID_66709879 | |
| 0.171 | 0.08 | 0.171 | Amyloid beta precursor protein antagonist | |||
| 0.132 | 0.042 | 0.301 | Xanthine oxidase inhibitor | 0.301 0.007 CID_66709879 | CID_66709879 | |
| 0.141 | 0.052 | 0.141 | Proteasome inhibitor | |||
| 0.105 | 0.015 | 0.105 | Purinergic P2X1 antagonist | 0.068 0.033 CID_66709879 | ||
| 0.1 | 0.01 | 0.1 | Beta 1 adrenoreceptor antagonist | |||
| 0.113 | 0.024 | 0.113 | Cannabinoid receptor antagonist | |||
| 0.092 | 0.004 | 0.092 | Leukotriene B4 receptor 1 antagonist | 0.064 0.005 CID_66709879 | ||
| 0.093 | 0.004 | 0.093 | Neuraminidase (Influenza A) inhibitor | 0.087 0.005 CID_66709879 | ||
| 0.091 | 0.004 | 0.091 | GABA uptake inhibitor | |||
| 0.121 | 0.034 | 0.121 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.098 | 0.012 | 0.098 | Thromboxane antagonist | |||
| 0.104 | 0.018 | 0.13 | Phosphodiesterase VI inhibitor | 0.13 0.01 CID_66709879 | CID_66709879 | |
| 0.089 | 0.005 | 0.089 | Adenylate cyclase 1 inhibitor | |||
| 0.141 | 0.058 | 0.141 | Cholinergic antagonist | |||
| 0.089 | 0.005 | 0.089 | Leukotriene C antagonist | 0.064 0.021 CID_66709879 | ||
| 0.091 | 0.008 | 0.091 | Thromboxane synthase inhibitor | |||
| 0.107 | 0.024 | 0.107 | Estrogen receptor alpha antagonist | |||
| 0.087 | 0.005 | 0.121 | Arginase inhibitor | 0.121 0.003 CID_66709879 | CID_66709879 | |
| 0.101 | 0.019 | 0.101 | NMDA receptor agonist | |||
| 0.113 | 0.032 | 0.113 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.108 | 0.027 | 0.108 | Myeloperoxidase inhibitor | |||
| 0.098 | 0.017 | 0.098 | Antimetabolite | 0.095 0.017 CID_66709879 | ||
| 0.084 | 0.003 | 0.084 | Toll-Like receptor 8 agonist | |||
| 0.176 | 0.096 | 0.42 | DNA methylase inhibitor | 0.42 0.01 CID_66709879 | CID_66709879 | |
| 0.195 | 0.114 | 0.546 | Tumour necrosis factor alpha release inhibitor | 0.546 0.01 CID_66709879 | CID_66709879 | |
| 0.116 | 0.036 | 0.116 | Androgen antagonist | |||
| 0.11 | 0.03 | 0.11 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.092 | 0.014 | 0.092 | Peroxisome proliferator-activated receptor alpha agonist | 0.063 0.025 CID_66709879 | ||
| 0.089 | 0.011 | 0.089 | Thromboxane A2 antagonist | |||
| 0.266 | 0.188 | 0.266 | Calcium channel L-type activator | |||
| 0.083 | 0.005 | 0.083 | Pregnane X receptor antagonist | |||
| 0.099 | 0.021 | 0.099 | Acetylcholine M5 receptor agonist | |||
| 0.161 | 0.083 | 0.161 | Dual specificity phosphatase inhibitor | |||
| 0.091 | 0.014 | 0.101 | Nitric oxide donor | 0.101 0.008 CID_66709879 | CID_66709879 | |
| 0.085 | 0.008 | 0.085 | Vanilloid 2 antagonist | |||
| 0.081 | 0.004 | 0.081 | Glutamate (mGluR1) agonist | |||
| 0.089 | 0.013 | 0.089 | Plasminogen activator inhibitor antagonist | |||
| 0.092 | 0.016 | 0.092 | Glutamate (mGluR7) antagonist | |||
| 0.135 | 0.059 | 0.135 | Acetylcholine antagonist | |||
| 0.095 | 0.019 | 0.095 | NMDA receptor glycine site agonist | |||
| 0.112 | 0.037 | 0.122 | Interleukin 12 antagonist | 0.122 0.028 CID_66709879 | CID_66709879 | |
| 0.093 | 0.018 | 0.093 | Xanthine dehydrogenase inhibitor | 0.052 0.044 CID_66709879 | ||
| 0.078 | 0.002 | 0.078 | Prostaglandin F2 alpha agonist | 0.036 0.006 CID_66709879 | ||
| 0.081 | 0.006 | 0.081 | Purinergic P2T antagonist | |||
| 0.083 | 0.009 | 0.083 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.212 | 0.139 | 0.212 | 12-Lipoxygenase inhibitor | |||
| 0.092 | 0.019 | 0.092 | Cannabinoid CB1 receptor antagonist | |||
| 0.093 | 0.021 | 0.093 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.094 | 0.022 | 0.094 | Ribonucleotide reductase inhibitor | |||
| 0.087 | 0.015 | 0.087 | Phosphodiesterase 1C inhibitor | |||
| 0.107 | 0.035 | 0.107 | Acetylcholine nicotinic antagonist | |||
| 0.075 | 0.004 | 0.078 | Uridine phosphorylase inhibitor | 0.078 0.004 CID_66709879 | CID_66709879 | |
| 0.097 | 0.026 | 0.097 | Amidase inhibitor | |||
| 0.086 | 0.015 | 0.086 | Toll-Like receptor 8 antagonist | |||
| 0.076 | 0.005 | 0.076 | Glutamate (mGluR3) antagonist | |||
| 0.082 | 0.011 | 0.082 | Beta 2 adrenoreceptor antagonist | |||
| 0.113 | 0.043 | 0.113 | Nitric-oxide synthase inhibitor | |||
| 0.078 | 0.009 | 0.078 | Thymidine kinase inhibitor | 0.049 0.019 CID_66709879 | ||
| 0.073 | 0.004 | 0.073 | Glutamate (mGluR1a) agonist | |||
| 0.073 | 0.004 | 0.073 | Kainate receptor agonist | 0.041 0.029 CID_66709879 | ||
| 0.106 | 0.038 | 0.106 | Phosphodiesterase I inhibitor | |||
| 0.078 | 0.01 | 0.078 | Beta 2 adrenoreceptor agonist | |||
| 0.075 | 0.008 | 0.075 | Fumarate hydratase inhibitor | 0.05 0.013 CID_66709879 | ||
| 0.071 | 0.004 | 0.072 | Guanylate cyclase inhibitor | 0.072 0.004 CID_66709879 | CID_66709879 | |
| 0.089 | 0.022 | 0.089 | Prostaglandin EP2 antagonist | 0.083 0.025 CID_66709879 | ||
| 0.071 | 0.005 | 0.071 | Delayed rectifier potassium channel blocker | |||
| 0.088 | 0.021 | 0.088 | Protein kinase C beta inhibitor | 0.067 0.053 CID_66709879 | ||
| 0.097 | 0.031 | 0.097 | Acetylcholine M4 receptor antagonist | |||
| 0.076 | 0.009 | 0.076 | Glutamate (mGluR1a) antagonist | |||
| 0.089 | 0.023 | 0.089 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.079 | 0.013 | 0.079 | Oleamide hydrolase inhibitor | |||
| 0.088 | 0.022 | 0.088 | Cannabinoid CB2 receptor agonist | |||
| 0.07 | 0.005 | 0.07 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.099 | 0.034 | 0.099 | Cathepsin G inhibitor | |||
| 0.094 | 0.029 | 0.094 | Epoxide hydrolase inhibitor | |||
| 0.125 | 0.06 | 0.205 | Protein-tyrosine phosphatase 1B inhibitor | 0.205 0.028 CID_66709879 | CID_66709879 | |
| 0.067 | 0.002 | 0.067 | Estrogen-related receptor gamma antagonist | |||
| 0.088 | 0.024 | 0.088 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.102 | 0.037 | 0.214 | Transcription factor NF kappa B stimulant | 0.214 0.008 CID_66709879 | CID_66709879 | |
| 0.079 | 0.015 | 0.079 | Calcium channel P-type blocker | |||
| 0.067 | 0.004 | 0.086 | Ceramide glucosyltransferase inhibitor | 0.086 0.003 CID_66709879 | CID_66709879 | |
| 0.121 | 0.058 | 0.121 | Transcription factor STAT6 inhibitor | |||
| 0.067 | 0.004 | 0.067 | Retinoic acid beta receptor agonist | |||
| 0.093 | 0.03 | 0.093 | Carbonic anhydrase V inhibitor | |||
| 0.065 | 0.002 | 0.065 | Carbonic anhydrase VIII inhibitor | 0.015 0.014 CID_66709879 | ||
| 0.065 | 0.002 | 0.065 | Carbonic anhydrase X inhibitor | 0.015 0.014 CID_66709879 | ||
| 0.084 | 0.022 | 0.084 | Androgen agonist | |||
| 0.072 | 0.01 | 0.072 | Retinoid X receptor agonist | |||
| 0.091 | 0.029 | 0.091 | Carbonic anhydrase VA inhibitor | |||
| 0.066 | 0.004 | 0.066 | Prostaglandin EP2 agonist | 0.041 0.008 CID_66709879 | ||
| 0.071 | 0.01 | 0.071 | Cholesterol esterase inhibitor | 0.052 0.027 CID_66709879 | ||
| 0.066 | 0.004 | 0.066 | Retinoid X receptor antagonist | |||
| 0.066 | 0.004 | 0.066 | Prostaglandin D2 agonist | 0.034 0.018 CID_66709879 | ||
| 0.125 | 0.064 | 0.271 | DNA repair enzyme inhibitor | 0.271 0.005 CID_66709879 | CID_66709879 | |
| 0.078 | 0.017 | 0.078 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.075 | 0.015 | 0.075 | Potassium channel (Inward rectifier) blocker | |||
| 0.067 | 0.007 | 0.067 | Retinoic acid alpha receptor agonist | |||
| 0.094 | 0.035 | 0.094 | Caspase 7 inhibitor | |||
| 0.064 | 0.005 | 0.064 | Leukotriene C4 antagonist | 0.042 0.019 CID_66709879 | ||
| 0.068 | 0.009 | 0.068 | Kainate receptor 2 antagonist | |||
| 0.075 | 0.017 | 0.081 | Lipocortins synthesis agonist | 0.081 0.013 CID_66709879 | CID_66709879 | |
| 0.074 | 0.016 | 0.074 | Epithelial sodium channel blocker | |||
| 0.13 | 0.072 | 0.13 | NADPH oxidase inhibitor | |||
| 0.072 | 0.014 | 0.114 | Adenine nucleotide translocase inhibitor | 0.114 0.004 CID_66709879 | CID_66709879 | |
| 0.096 | 0.039 | 0.096 | Histamine H2 receptor antagonist | |||
| 0.094 | 0.037 | 0.094 | D-Ala-D-Ala ligase inhibitor | |||
| 0.068 | 0.012 | 0.068 | Dihydroorotase inhibitor | |||
| 0.083 | 0.027 | 0.083 | Potassium channel (Tandem pore domain) blocker | |||
| 0.107 | 0.051 | 0.107 | Estrogen receptor beta antagonist | |||
| 0.116 | 0.06 | 0.116 | GABA receptor agonist | |||
| 0.066 | 0.01 | 0.066 | Retinoid X alpha receptor agonist | |||
| 0.062 | 0.006 | 0.062 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.08 | 0.024 | 0.08 | Acetylcholine M5 receptor antagonist | |||
| 0.061 | 0.005 | 0.061 | Angiotensin AT1 receptor antagonist | |||
| 0.075 | 0.02 | 0.075 | Phosphodiesterase 1A inhibitor | |||
| 0.063 | 0.008 | 0.063 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.061 | 0.007 | 0.061 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.034 0.015 CID_66709879 | ||
| 0.105 | 0.051 | 0.105 | Potassium channel (Ca-activated) activator | |||
| 0.073 | 0.019 | 0.15 | Carbonic anhydrase XIV inhibitor | 0.15 0.005 CID_66709879 | CID_66709879 | |
| 0.057 | 0.003 | 0.057 | Calcium-independent phospholipase A2 inhibitor | 0.039 0.012 CID_66709879 | ||
| 0.095 | 0.041 | 0.095 | Inducible nitric-oxide synthase inhibitor | |||
| 0.059 | 0.005 | 0.059 | Vanilloid 3 antagonist | |||
| 0.129 | 0.076 | 0.157 | Alkaline phosphatase inhibitor | 0.157 0.055 CID_66709879 | CID_66709879 | |
| 0.079 | 0.026 | 0.079 | Exportin-1 inhibitor | |||
| 0.067 | 0.014 | 0.067 | 5-Alpha-reductase inhibitor | |||
| 0.168 | 0.116 | 0.168 | Histone acetyltransferase inhibitor | |||
| 0.065 | 0.013 | 0.065 | Oxytocin agonist | |||
| 0.078 | 0.026 | 0.078 | Maillard reaction inhibitor | |||
| 0.056 | 0.004 | 0.056 | Retinoid X alpha receptor antagonist | |||
| 0.055 | 0.004 | 0.055 | Glutamate (mGluR3) agonist | 0.039 0.011 CID_66709879 | ||
| 0.074 | 0.023 | 0.074 | Cyclin D1 inhibitor | |||
| 0.062 | 0.011 | 0.062 | Dopamine D5 agonist | |||
| 0.078 | 0.027 | 0.078 | Carbonic anhydrase stimulant | |||
| 0.108 | 0.058 | 0.108 | Urease inhibitor | |||
| 0.13 | 0.08 | 0.13 | Histone deacetylase SIRT1 inhibitor | |||
| 0.069 | 0.019 | 0.069 | Ryanodine receptor antagonist | |||
| 0.073 | 0.025 | 0.073 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.121 | 0.073 | 0.121 | MAP kinase kinase inhibitor | |||
| 0.056 | 0.008 | 0.056 | Glutamate (mGluR8) agonist | |||
| 0.077 | 0.029 | 0.077 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.053 | 0.005 | 0.053 | Angiotensin II receptor antagonist | |||
| 0.064 | 0.017 | 0.064 | Immunoglobulin Fc receptor antagonist | |||
| 0.053 | 0.005 | 0.053 | Prostaglandin E2 agonist | |||
| 0.192 | 0.145 | 0.192 | Transcription factor STAT3 inhibitor | |||
| 0.063 | 0.016 | 0.063 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.054 | 0.007 | 0.054 | Free fatty acid receptor 1 antagonist | |||
| 0.075 | 0.028 | 0.075 | NMDA 2C receptor antagonist | |||
| 0.064 | 0.017 | 0.064 | Aldosterone antagonist | |||
| 0.092 | 0.046 | 0.092 | Hematopoietic | |||
| 0.049 | 0.003 | 0.068 | Vanilloid 2 agonist | 0.068 0.002 CID_66709879 | CID_66709879 | |
| 0.049 | 0.003 | 0.049 | Hedgehog signaling activator | |||
| 0.064 | 0.018 | 0.302 | Heparanase inhibitor | 0.302 0.001 CID_66709879 | CID_66709879 | |
| 0.053 | 0.007 | 0.053 | Melatonin receptor 1A agonist | |||
| 0.094 | 0.049 | 0.124 | ATPase (Vacuolar H+) inhibitor | 0.124 0.017 CID_66709879 | CID_66709879 | |
| 0.058 | 0.013 | 0.058 | GABA B receptor antagonist | |||
| 0.056 | 0.011 | 0.056 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.08 | 0.035 | 0.08 | Sirtuin 1 inhibitor | |||
| 0.082 | 0.037 | 0.082 | Calcium channel L-type blocker | |||
| 0.049 | 0.005 | 0.049 | Retinoic acid receptor agonist | |||
| 0.05 | 0.006 | 0.134 | Sodium/glucose cotransporter 2 inhibitor | 0.134 0.002 CID_66709879 | CID_66709879 | |
| 0.055 | 0.012 | 0.055 | AMPA 4 receptor antagonist | |||
| 0.045 | 0.003 | 0.045 | Isoleucine-tRNA ligase inhibitor | 0.036 0.004 CID_66709879 | ||
| 0.098 | 0.055 | 0.2 | Uric acid excretion stimulant | 0.2 0.013 CID_66709879 | CID_66709879 | |
| 0.051 | 0.009 | 0.051 | Peptide deformylase inhibitor | |||
| 0.061 | 0.019 | 0.061 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.044 | 0.002 | 0.044 | Thromboxane A2 agonist | |||
| 0.046 | 0.005 | 0.046 | Purinergic P2Y15 antagonist | 0.031 0.016 CID_66709879 | ||
| 0.047 | 0.005 | 0.047 | Adenosine uptake inhibitor | |||
| 0.07 | 0.028 | 0.07 | Heat shock protein 90 beta antagonist | |||
| 0.143 | 0.102 | 0.143 | Dual specificity phosphatase 3 inhibitor | |||
| 0.052 | 0.011 | 0.052 | Acetylcholine M4 receptor agonist | |||
| 0.044 | 0.003 | 0.044 | Neuraminidase (Influenza B) inhibitor | 0.031 0.004 CID_66709879 | ||
| 0.096 | 0.055 | 0.096 | Protein kinase C zeta inhibitor | |||
| 0.045 | 0.004 | 0.045 | DNA polymerase III inhibitor | |||
| 0.053 | 0.014 | 0.079 | Squalene synthetase inhibitor | 0.079 0.008 CID_66709879 | CID_66709879 | |
| 0.054 | 0.014 | 0.054 | Dihydropteroate synthase inhibitor | |||
| 0.043 | 0.004 | 0.075 | Ileal bile acid transport inhibitor | 0.075 0.003 CID_66709879 | CID_66709879 | |
| 0.146 | 0.106 | 0.146 | Tumour necrosis factor antagonist | |||
| 0.052 | 0.013 | 0.052 | Nicotinic acid receptor 2 agonist | |||
| 0.062 | 0.023 | 0.062 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.059 | 0.02 | 0.059 | NMDA receptor subunit 3B antagonist | |||
| 0.135 | 0.096 | 0.135 | MAP kinase 3 inhibitor | |||
| 0.052 | 0.014 | 0.052 | Beta adrenoreceptor agonist | |||
| 0.04 | 0.003 | 0.04 | Thromboxane agonist | |||
| 0.042 | 0.005 | 0.042 | Nicotinic acid receptor 2 antagonist | |||
| 0.042 | 0.004 | 0.042 | Acid ceramidase inhibitor | |||
| 0.067 | 0.03 | 0.067 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.04 | 0.004 | 0.04 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.1 | 0.064 | 0.1 | Folate antagonist | 0.1 0.064 CID_66709879 | ||
| 0.06 | 0.024 | 0.06 | Bombesin 2 receptor antagonist | |||
| 0.062 | 0.027 | 0.062 | Autotaxin inhibitor | |||
| 0.065 | 0.03 | 0.065 | Acetylcholine muscarinic agonist | |||
| 0.068 | 0.033 | 0.068 | Phosphodiesterase 1B inhibitor | |||
| 0.042 | 0.006 | 0.152 | Sodium/glucose cotransporter inhibitor | 0.152 0.002 CID_66709879 | CID_66709879 | |
| 0.046 | 0.011 | 0.046 | Carnitine palmitoyltransferase inhibitor | |||
| 0.04 | 0.005 | 0.04 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.053 | 0.018 | 0.053 | Glutamate (mGluR4) antagonist | |||
| 0.065 | 0.03 | 0.065 | Fatty acid synthase inhibitor | |||
| 0.039 | 0.005 | 0.046 | Leukotriene B4 receptor 2 antagonist | 0.046 0.005 CID_66709879 | CID_66709879 | |
| 0.049 | 0.015 | 0.049 | Heme oxygenase inhibitor | |||
| 0.05 | 0.017 | 0.05 | Calcitonin receptor agonist | |||
| 0.051 | 0.017 | 0.051 | Plasmepsin II inhibitor | |||
| 0.048 | 0.014 | 0.048 | Prostacyclin antagonist | |||
| 0.037 | 0.003 | 0.037 | Estrogen-related receptor gamma agonist | |||
| 0.048 | 0.014 | 0.048 | MAP3K5 inhibitor | |||
| 0.049 | 0.015 | 0.049 | Diamine oxidase inhibitor | |||
| 0.045 | 0.012 | 0.045 | Liver X receptor beta agonist | |||
| 0.043 | 0.011 | 0.043 | ATP citrate lysase inhibitor | |||
| 0.043 | 0.011 | 0.043 | Cholesterol ester transfer protein antagonist | |||
| 0.066 | 0.034 | 0.067 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.067 0.033 CID_66709879 | CID_66709879 | |
| 0.037 | 0.004 | 0.037 | G-protein-coupled receptor 120 agonist | |||
| 0.044 | 0.012 | 0.044 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.058 | 0.026 | 0.058 | Metalloproteinase-3 inhibitor | |||
| 0.188 | 0.156 | 0.188 | Transcription factor STAT inhibitor | |||
| 0.035 | 0.003 | 0.035 | Vitamin D receptor agonist | 0.029 0.004 CID_66709879 | ||
| 0.073 | 0.042 | 0.073 | Neuronal nicotinic receptor antagonist | |||
| 0.074 | 0.043 | 0.074 | Secretase beta inhibitor | |||
| 0.036 | 0.005 | 0.036 | Glucosylceramidase stimulant | |||
| 0.051 | 0.021 | 0.051 | Histamine H2 receptor agonist | |||
| 0.072 | 0.042 | 0.072 | Matrix metalloproteinase inhibitor | |||
| 0.04 | 0.01 | 0.04 | Lysine carboxypeptidase inhibitor | |||
| 0.034 | 0.004 | 0.034 | Retinoid X beta receptor antagonist | |||
| 0.035 | 0.005 | 0.035 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.054 | 0.024 | 0.054 | Dopamine D2 agonist | |||
| 0.154 | 0.125 | 0.154 | Anticonvulsant | |||
| 0.05 | 0.021 | 0.05 | Kainate receptor antagonist | |||
| 0.044 | 0.015 | 0.044 | Sirtuin 2 inhibitor | |||
| 0.036 | 0.008 | 0.036 | Prostaglandin H2 antagonist | |||
| 0.056 | 0.028 | 0.056 | Prolyl endopeptidase inhibitor | |||
| 0.033 | 0.006 | 0.033 | Vitamin D receptor antagonist | 0.023 0.012 CID_66709879 | ||
| 0.049 | 0.022 | 0.049 | Glutamate (mGluR group III) antagonist | |||
| 0.034 | 0.007 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.037 0.005 CID_66709879 | CID_66709879 | |
| 0.052 | 0.025 | 0.052 | Thymidylate synthase inhibitor | |||
| 0.055 | 0.03 | 0.055 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.03 | 0.005 | 0.03 | Thyroid hormone alpha antagonist | |||
| 0.059 | 0.033 | 0.059 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.058 | 0.033 | 0.058 | Dihydroorotate oxidase inhibitor | |||
| 0.082 | 0.057 | 0.082 | CC chemokine 5 receptor agonist | |||
| 0.082 | 0.057 | 0.082 | Thioredoxin reductase inhibitor | |||
| 0.031 | 0.006 | 0.031 | Retinoic acid gamma receptor agonist | |||
| 0.039 | 0.015 | 0.039 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.075 | 0.051 | 0.075 | Adenosine A3 receptor antagonist | |||
| 0.029 | 0.005 | 0.029 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.106 | 0.082 | 0.194 | Beta amyloid protein antagonist | 0.194 0.019 CID_66709879 | CID_66709879 | |
| 0.046 | 0.023 | 0.046 | Liver X receptor alpha agonist | |||
| 0.038 | 0.015 | 0.038 | Carboxypeptidase B inhibitor | |||
| 0.03 | 0.007 | 0.03 | Prostaglandin EP4 agonist | |||
| 0.033 | 0.009 | 0.033 | Thymidine phosphorylase inhibitor | |||
| 0.058 | 0.035 | 0.058 | Cyclin B2 inhibitor | |||
| 0.044 | 0.021 | 0.044 | G protein-coupled receptor agonist | |||
| 0.051 | 0.028 | 0.051 | Dopamine beta hydroxylase inhibitor | |||
| 0.035 | 0.012 | 0.035 | Angiotensin AT2 receptor antagonist | |||
| 0.029 | 0.006 | 0.029 | Prostacyclin agonist | |||
| 0.069 | 0.046 | 0.069 | Protein kinase C alpha inhibitor | |||
| 0.048 | 0.026 | 0.048 | Acetylcholine M1 receptor agonist | |||
| 0.035 | 0.013 | 0.035 | Leukotriene D4 antagonist | 0.024 0.02 CID_66709879 | ||
| 0.032 | 0.01 | 0.032 | Thyroid hormone agonist | |||
| 0.036 | 0.015 | 0.036 | Liver X receptor beta antagonist | |||
| 0.061 | 0.039 | 0.061 | Adenosine A1 receptor antagonist | |||
| 0.031 | 0.01 | 0.057 | Toll-Like receptor 4 agonist | 0.057 0.003 CID_66709879 | CID_66709879 | |
| 0.031 | 0.009 | 0.031 | 5-Alpha-reductase 2 inhibitor | |||
| 0.056 | 0.035 | 0.056 | Matrix metalloproteinase 1 inhibitor | |||
| 0.063 | 0.042 | 0.063 | Acetylcholine M2 receptor antagonist | |||
| 0.065 | 0.044 | 0.065 | Neutrophil collagenase inhibitor | |||
| 0.052 | 0.031 | 0.052 | Potassium channel (Inward rectifier) activator | |||
| 0.033 | 0.012 | 0.033 | LFA antagonist | |||
| 0.044 | 0.023 | 0.044 | NMDA receptor subunit 3A antagonist | |||
| 0.177 | 0.157 | 0.177 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.062 | 0.042 | 0.062 | Cyclin B1 inhibitor | |||
| 0.053 | 0.033 | 0.053 | H+/K+-transporting ATPase inhibitor | |||
| 0.037 | 0.017 | 0.037 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.05 | 0.03 | 0.05 | Potassium channel (ATP-sensitive) activator | |||
| 0.024 | 0.005 | 0.033 | Telomerase stimulant | 0.033 0.003 CID_66709879 | CID_66709879 | |
| 0.033 | 0.014 | 0.033 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.153 | 0.134 | 0.153 | Growth factor agonist | |||
| 0.069 | 0.05 | 0.069 | Prostaglandin-E synthase inhibitor | |||
| 0.034 | 0.015 | 0.034 | Cyclin E2 inhibitor | |||
| 0.06 | 0.041 | 0.06 | Acetylcholine M3 receptor antagonist | |||
| 0.048 | 0.03 | 0.048 | Benzodiazepine antagonist | |||
| 0.05 | 0.032 | 0.05 | HCV NS3/NS4A protease inhibitor | |||
| 0.058 | 0.04 | 0.058 | Cathepsin L inhibitor | |||
| 0.045 | 0.027 | 0.045 | Dihydrofolate reductase inhibitor | |||
| 0.023 | 0.005 | 0.023 | Purinergic P2Y1 agonist | 0.017 0.009 CID_66709879 | ||
| 0.024 | 0.006 | 0.048 | Antibiotic Anthracycline-like | 0.048 0.002 CID_66709879 | CID_66709879 | |
| 0.021 | 0.004 | 0.021 | Carbonic anhydrase XI inhibitor | |||
| 0.022 | 0.005 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.013 CID_66709879 | ||
| 0.047 | 0.03 | 0.047 | Phosphodiesterase 6C inhibitor | |||
| 0.026 | 0.009 | 0.026 | 5-Alpha-reductase 1 inhibitor | |||
| 0.04 | 0.023 | 0.04 | Factor XIIIa inhibitor | |||
| 0.034 | 0.019 | 0.034 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.039 | 0.025 | 0.039 | Farnesoid X receptor agonist | |||
| 0.019 | 0.004 | 0.019 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.029 | 0.015 | 0.029 | Retinoid X gamma receptor antagonist | |||
| 0.04 | 0.026 | 0.04 | Histone deacetylase 9 inhibitor | |||
| 0.035 | 0.021 | 0.035 | Melatonin 2 agonist | |||
| 0.018 | 0.004 | 0.018 | DNA polymerase III polC-type inhibitor | |||
| 0.061 | 0.047 | 0.061 | Histone deacetylase SIRT3 inhibitor | |||
| 0.062 | 0.048 | 0.062 | Dopamine D1 antagonist | |||
| 0.029 | 0.016 | 0.029 | Prostaglandin EP4 antagonist | |||
| 0.025 | 0.012 | 0.025 | ICAM 1 antagonist | |||
| 0.024 | 0.011 | 0.024 | Angiotensin AT1A receptor antagonist | |||
| 0.032 | 0.019 | 0.032 | Epoxide hydrolase 1 inhibitor | |||
| 0.017 | 0.005 | 0.017 | Cyclin D2 inhibitor | |||
| 0.059 | 0.046 | 0.059 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.038 | 0.026 | 0.038 | Leukotriene A4 hydrolase inhibitor | |||
| 0.018 | 0.007 | 0.018 | Angiotensin AT1B receptor antagonist | |||
| 0.053 | 0.042 | 0.053 | Phosphodiesterase II inhibitor | |||
| 0.111 | 0.099 | 0.111 | Cytokine production inhibitor | |||
| 0.037 | 0.026 | 0.037 | Histone deacetylase 7 inhibitor | |||
| 0.028 | 0.017 | 0.028 | Myristoyl transferase inhibitor | |||
| 0.026 | 0.015 | 0.026 | Dopamine autoreceptor agonist | |||
| 0.02 | 0.009 | 0.02 | Nicotinic acid receptor 1 antagonist | |||
| 0.069 | 0.058 | 0.069 | Metalloproteinase-9 inhibitor | |||
| 0.024 | 0.014 | 0.024 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.021 | 0.01 | 0.021 | Retinoic acid receptor antagonist | |||
| 0.015 | 0.004 | 0.015 | Angiotensin AT2 receptor agonist | |||
| 0.034 | 0.024 | 0.034 | HMG CoA reductase inhibitor | 0.032 0.028 CID_66709879 | ||
| 0.024 | 0.014 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.052 | 0.042 | 0.088 | Protein kinase C eta inhibitor | 0.088 0.02 CID_66709879 | CID_66709879 | |
| 0.048 | 0.039 | 0.048 | Factor III inhibitor | 0.048 0.04 CID_66709879 | ||
| 0.019 | 0.01 | 0.019 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.066 | 0.056 | 0.066 | Phosphodiesterase V inhibitor | |||
| 0.023 | 0.014 | 0.023 | Follicle-stimulating hormone agonist | |||
| 0.025 | 0.016 | 0.025 | 5 Hydroxytryptamine 4 agonist | |||
| 0.033 | 0.024 | 0.033 | Melatonin 1 agonist | |||
| 0.018 | 0.009 | 0.018 | Adenosine A2 receptor agonist | 0.015 0.013 CID_66709879 | ||
| 0.035 | 0.026 | 0.035 | Glutamate (mGluR8) antagonist | |||
| 0.072 | 0.063 | 0.072 | Metalloproteinase-2 inhibitor | |||
| 0.056 | 0.047 | 0.056 | Collagenase 3 inhibitor | |||
| 0.064 | 0.057 | 0.064 | Phosphodiesterase 5A inhibitor | |||
| 0.023 | 0.015 | 0.023 | Beta 1 adrenoreceptor agonist | |||
| 0.022 | 0.014 | 0.022 | Kainate receptor 1 antagonist | |||
| 0.02 | 0.013 | 0.02 | Follicle-stimulating hormone antagonist | |||
| 0.01 | 0.003 | 0.01 | DNA polymerase III subunit alpha inhibitor | |||
| 0.011 | 0.004 | 0.011 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.013 | 0.007 | 0.013 | Purine nucleoside phosphorylase inhibitor | |||
| 0.016 | 0.01 | 0.016 | Adenosine A2a receptor agonist | |||
| 0.013 | 0.007 | 0.013 | Glutamate (mGluR6) agonist | |||
| 0.04 | 0.034 | 0.04 | Leukocyte elastase inhibitor | |||
| 0.02 | 0.014 | 0.02 | Retinoic acid alpha receptor antagonist | |||
| 0.043 | 0.038 | 0.043 | Parathyroid hormone antagonist | |||
| 0.09 | 0.084 | 0.09 | Glutamate (mGluR7) agonist | |||
| 0.027 | 0.022 | 0.027 | AMPA 3 receptor antagonist | |||
| 0.019 | 0.014 | 0.019 | Caspase 8 inhibitor | |||
| 0.028 | 0.023 | 0.028 | Glucagon receptor antagonist | |||
| 0.098 | 0.093 | 0.436 | Cell adhesion inhibitor | 0.436 0.005 CID_66709879 | CID_66709879 | |
| 0.025 | 0.02 | 0.025 | CXC chemokine 2 receptor antagonist | |||
| 0.023 | 0.019 | 0.023 | Phosphodiesterase 6A inhibitor | |||
| 0.218 | 0.214 | 0.218 | DNA directed DNA polymerase inhibitor | |||
| 0.026 | 0.022 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.137 | 0.134 | 0.137 | I kappa B kinase epsilon inhibitor | |||
| 0.045 | 0.042 | 0.045 | Phosphodiesterase 2A inhibitor | |||
| 0.04 | 0.037 | 0.092 | Phosphorylase inhibitor | 0.092 0.014 CID_66709879 | CID_66709879 | |
| 0.05 | 0.047 | 0.05 | Cyclin B inhibitor | |||
| 0.075 | 0.073 | 0.075 | Acetylcholine agonist | |||
| 0.09 | 0.088 | 0.245 | Beta glucuronidase inhibitor | 0.245 0.009 CID_66709879 | CID_66709879 | |
| 0.009 | 0.007 | 0.009 | Corticotropin releasing factor antagonist | |||
| 0.035 | 0.034 | 0.035 | Vascular adhesion protein 1 inhibitor | |||
| 0.034 | 0.033 | 0.034 | Glutamate (mGluR group II) antagonist | |||
| 0.041 | 0.042 | 0.053 | Estrogen agonist | 0.053 0.034 CID_66709879 | CID_66709879 | |
| 0.008 | 0.012 | 0.012 | Purinergic P2Y2 agonist | 0.012 0.005 CID_66709879 | CID_66709879 | |
| 0.017 | 0.022 | 0.029 | Corticosteroid-like | 0.029 0.007 CID_66709879 | CID_66709879 | |
| 0.031 | 0.035 | 0.087 | Antibiotic Aminoglycoside-like | 0.087 0.004 CID_66709879 | CID_66709879 | |
| 0.062 | 0.071 | 0.254 | Antineoplastic antibiotic | 0.254 0.014 CID_66709879 | CID_66709879 | |
| 0.061 | 0.072 | 0.199 | Topoisomerase II alpha inhibitor | 0.199 0.015 CID_66709879 | CID_66709879 | |
| 0.046 | 0.06 | 0.053 | Carbonic anhydrase inhibitor | 0.053 0.052 CID_66709879 | CID_66709879 | |
| 0.062 | 0.093 | 0.302 | Cell adhesion molecule inhibitor | 0.302 0.005 CID_66709879 | CID_66709879 | |
| 0.031 | 0.073 | 0.059 | Microtubule stabilization | 0.059 0.015 CID_66709879 | CID_66709879 | |
| 0.023 | 0.068 | 0.072 | Carbonic anhydrase XII inhibitor | 0.072 0.028 CID_66709879 | CID_66709879 | |
| 0.003 | 0.052 | 0.018 | Antibiotic Macrolide-like | 0.018 0.008 CID_66709879 | CID_66709879 | |
| 0.013 | 0.068 | 0.07 | Protein 30S ribosomal subunit inhibitor | 0.07 0.005 CID_66709879 | CID_66709879 | |
| 0.02 | 0.077 | 0.05 | Carbonic anhydrase IX inhibitor | 0.05 0.043 CID_66709879 | CID_66709879 | |
| 0.057 | 0.125 | 0.296 | Topoisomerase I inhibitor | 0.296 0.011 CID_66709879 | CID_66709879 | |
| 0.025 | 0.102 | 0.131 | Protein 50S ribosomal subunit inhibitor | 0.131 0.008 CID_66709879 | CID_66709879 | |
| 0.16 | 0.248 | 0.345 | Caspase 3 stimulant | 0.345 0.061 CID_66709879 | CID_66709879 | |
| 0.162 | 0.251 | 0.479 | Alpha-glucosidase inhibitor | 0.479 0.086 CID_66709879 | CID_66709879 | |
| 0.008 | 0.103 | 0.021 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.021 0.005 CID_66709879 | CID_66709879 | |
| 0.056 | 0.156 | 0.125 | DNA intercalator | 0.125 0.055 CID_66709879 | CID_66709879 | |
| 0.158 | 0.263 | 0.262 | Antiobesity | 0.262 0.145 CID_66709879 | CID_66709879 | |
| 0.02 | 0.128 | 0.037 | Protein kinase C beta I inhibitor | 0.037 0.013 CID_66709879 | CID_66709879 | |
| 0.017 | 0.148 | 0.054 | Aldose reductase inhibitor | 0.054 0.036 CID_66709879 | CID_66709879 | |
| 0.046 | 0.188 | 0.251 | Topoisomerase II inhibitor | 0.251 0.024 CID_66709879 | CID_66709879 | |
| 0.065 | 0.234 | 0.311 | Anticoagulant | 0.311 0.027 CID_66709879 | CID_66709879 | |
| 0.02 | 0.276 | 0.094 | Glucose-6-phosphate translocase inhibitor | 0.094 0.007 CID_66709879 | CID_66709879 | |
| 0.023 | 0.454 | 0.141 | Multidrug resistance-associated protein 1 inhibitor | 0.141 0.03 CID_66709879 | CID_66709879 | |
| 0.05 | 0.489 | 0.257 | Angiogenesis inhibitor | 0.257 0.117 CID_66709879 | CID_66709879 | |
| 0.015 | 0.58 | 0.091 | Factor IXa inhibitor | 0.091 0.012 CID_66709879 | CID_66709879 | |
| 0.073 | 0.639 | 0.148 | CC chemokine 6 receptor antagonist | 0.148 0.025 CID_66709879 | CID_66709879 | |
| 0.034 | 0.663 | 0.336 | NOS3 expression enhancer | 0.336 0.013 CID_66709879 | CID_66709879 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |